Notman Donald
SEC CIK 1718019 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | See Remarks | 366.5K | — | $394.7K | 14 | 2022-02-03 | 2026-08-31 |
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 16:01 | 2026-08-31 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | COO | S - Sale | $10.24 | -1,099 | 366.5K | -0.3% | -$11.3K | |
| 2026-02-17 | 2026-02-12 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | COO | S - Sale | $9.04 | -11.4K | 366.4K | -3% | -$103.5K | |
| M | 2026-02-04 | 2026-02-02+ | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | COO | S - Sale | $8.82 | -11.5K | 383.8K | -3% | -$101.4K |
| D | 2026-01-06 | 2026-01-02 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | See Remarks | A - Grant | $0.00 | +79.1K | 389.3K | +26% | $0 |
| 2025-09-04 | 2025-09-02 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | See Remarks | S - Sale | $12.43 | -1,066 | 308.8K | -0.3% | -$13.3K | |
| D | 2025-02-13 | 2025-02-11 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | See Remarks | A - Grant | $0.00 | +115.0K | 308.4K | +59% | $0 |
| M | 2025-02-04 | 2025-01-31+ | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | See Remarks | S - Sale | $7.82 | -17.4K | 204.6K | -8% | -$136.2K |
| D | 2024-09-03 | 2024-08-29 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | See Remarks | A - Grant | $0.00 | +11.0K | 209.0K | +6% | $0 |
| D | 2024-02-06 | 2024-02-03 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | CFO | A - Grant | $0.00 | +61.6K | 201.6K | +44% | $0 |
| D | 2024-02-06 | 2024-02-05 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | CFO | S - Sale | $4.86 | +6,212 | 195.4K | +3% | +$30.2K |
| 2024-02-02 | 2024-01-31 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | CFO | S - Sale | $4.95 | -6,433 | 139.9K | -4% | -$31.8K | |
| 2023-02-08 | 2023-02-06 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | CFO | S - Sale | $4.24 | -6,476 | 139.4K | -4% | -$27.5K | |
| D | 2023-02-01 | 2023-01-30 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | CFO | A - Grant | $0.00 | +55.6K | 145.9K | +62% | $0 |
| D | 2022-02-07 | 2022-02-03 | OCUL | OCULAR THERAPEUTIX, INC | Notman Donald | CFO | A - Grant | $0.00 | +55.6K | 81.6K | +213% | $0 |
Purchase Sale Sale after option exercise All abbreviations